We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $7.06B
1-Year Est. Return 3.43%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$17.3B
AUM Growth
+$1.97B
Cap. Flow
+$1.27B
Cap. Flow %
7.3%
Top 10 Hldgs %
48.13%
Holding
28
New
1
Increased
24
Reduced
3
Closed

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$577M
2
STT icon
State Street
STT
+$274M
3
GWW icon
W.W. Grainger
GWW
+$174M
4
PH icon
Parker-Hannifin
PH
+$57.4M
5
PGR icon
Progressive
PGR
+$43M

Top Sells

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$308M
2
FISV
Fiserv Inc
FISV
+$71.9M
3
ACN icon
Accenture
ACN
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 28.21%
2 Financials 27.88%
3 Technology 18.7%
4 Industrials 15.03%
5 Consumer Discretionary 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AON icon
1
Aon
AON
$80.5B
$891M 5.14%
6,700,077
+114,690
+2% +$14.5M
PGR icon
2
Progressive
PGR
$129B
$862M 4.97%
19,547,018
+1,035,246
+6% +$43M
APTV icon
3
Aptiv
APTV
$12.4B
$857M 4.94%
9,772,666
+300,071
+3% +$25M
BNY
4
Bank of New York Mellon
BNY
$105B
$843M 4.86%
16,519,184
+726,898
+5% +$34.8M
UNH icon
5
UnitedHealth
UNH
$387B
$836M 4.82%
4,510,545
+151,208
+3% +$26.5M
PH icon
6
Parker-Hannifin
PH
$119B
$821M 4.73%
5,134,958
+362,076
+8% +$57.4M
ZBH icon
7
Zimmer Biomet
ZBH
$18.7B
$819M 4.72%
6,569,042
+277,259
+4% +$32.9M
ORCL icon
8
Oracle
ORCL
$338B
$815M 4.7%
16,247,371
+716,802
+5% +$32.7M
FIS icon
9
Fidelity National Information Services
FIS
$23.8B
$812M 4.68%
9,504,642
+428,628
+5% +$35.9M
HCA icon
10
HCA Healthcare
HCA
$91.4B
$792M 4.57%
9,081,454
+414,598
+5% +$35.1M
IQV icon
11
IQVIA
IQV
$40.4B
$780M 4.5%
8,711,447
+505,526
+6% +$42.7M
WTW icon
12
Willis Towers Watson
WTW
$30.3B
$774M 4.46%
5,322,466
+256,179
+5% +$35.8M
EMR icon
13
Emerson Electric
EMR
$82.1B
$753M 4.34%
12,624,050
+526,712
+4% +$31.2M
TMO icon
14
Thermo Fisher Scientific
TMO
$215B
$742M 4.28%
4,251,131
+84,180
+2% +$14.1M
WFC icon
15
Wells Fargo
WFC
$257B
$695M 4.01%
12,544,667
+636,994
+5% +$34.1M
STT icon
16
State Street
STT
$49.1B
$679M 3.92%
7,569,482
+3,290,082
+77% +$274M
GWW icon
17
W.W. Grainger
GWW
$64.4B
$678M 3.91%
3,755,706
+923,948
+33% +$174M
ACN icon
18
Accenture
ACN
$107B
$637M 3.68%
5,153,945
-135,366
-3% -$16.5M
PFE icon
19
Pfizer
PFE
$144B
$620M 3.58%
19,465,875
+1,253,268
+7% +$39.5M
DG icon
20
Dollar General
DG
$28.1B
$578M 3.33%
+8,011,492
New +$577M
FISV
21
Fiserv Inc
FISV
$29.6B
$535M 3.08%
8,742,796
-1,188,480
-12% -$71.9M
TMX
22
DELISTED
Terminix Global Holdings, Inc.
TMX
$356M 2.05%
13,546,286
+694,140
+5% +$18.2M
OMC icon
23
Omnicom Group
OMC
$23.6B
$332M 1.91%
4,000,490
+213,081
+6% +$17.8M
MD icon
24
Pediatrix Medical
MD
$2.18B
$303M 1.75%
5,023,476
+467,845
+10% +$27.7M
ARW icon
25
Arrow Electronics
ARW
$10.5B
$219M 1.26%
2,792,564
+116,338
+4% +$8.69M

Similar funds

Longview Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Longview Partners held 28 positions worth $17.3B, up 13% from $15.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Longview Partners deployed $1.27B of net new capital in Q2 2017, opening 1 new position and adding to 24 existing holdings. Its largest new stake was Dollar General: 8,011,492 shares worth $578M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was TE Connectivity, an estimated $308M trimmed.

  • Longview Partners's largest Q2 2017 buy was Dollar General: 8,011,492 shares worth $578M.
  • Longview Partners added most to State Street in Q2 2017, an estimated $274M increase.
  • Longview Partners's biggest Q2 2017 reduction was TE Connectivity, cutting an estimated $308M.
  • Longview Partners's ten largest holdings make up 48% of its $17.3B portfolio in Q2 2017.
  • Longview Partners opened 1 new position and closed 0 in Q2 2017.
  • Longview Partners's portfolio value rose 13% quarter-over-quarter to $17.3B.

Based on Longview Partners's 13F filing for Q2 2017, filed 26 Jul 2017.